The Advanced Research Projects Agency for Health (ARPA-H) has announced an upcoming solicitation for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) contracts for FY2024. The initiative targets innovative firms capable of conducting cutting-edge research and development, with a focus on commercializing the results. The solicitation includes opportunities for Phase I, Direct to Phase II, and Fast Track contracts.
Program Overview and Objectives
The SBIR/STTR program aims to:
- Stimulate technological innovation.
- Strengthen the role of small businesses in federal research and development.
- Encourage participation from socially and economically disadvantaged small businesses and women-owned business concerns.
- Increase private sector commercialization of innovations derived from federal R&D, boosting competition, productivity, and economic growth.
Eligible small business concerns must be U.S.-based, for-profit entities with fewer than 500 employees, and majority-owned by U.S. citizens or permanent residents, or by certain venture capital, hedge funds, or private equity firms.
FY2024 SBIR/STTR Topic Areas
The solicitation will cover the following ARPA-H FY2024 SBIR/STTR topic areas:
- Ambulatory Edema Monitor: Development of a wearable tool to detect early subclinical edema, addressing a significant gap in lymphatic medicine, especially in rural areas.
- Predictive Language Models for Cognitive Disability Adaptive Communication Tools: Creation of intelligent, adaptive communication tools for individuals with speech or language impairments to enhance their educational, social, and workplace interactions.
- Cell and Gene Therapy Process Analytical Technology and Quality Control Testing: Solutions for high manufacturing costs and drug shortages through advanced process analytical technologies and rapid, automated quality testing.
- Wearable Cell Sorting and Gene Delivery Systems: Innovative formats for cell and gene therapy delivery that improve targeting efficiency and overcome existing logistical and targeting challenges.
- Precision Brain Targeting: Non-invasive methods for precise and timely brain targeting for treating neurological or psychiatric disorders, focusing on specific brain regions, cell types, and timing.
- NutriTech: Revolutionizing Personalized Food as Medicine: Digital health tools and diagnostics that use dietary habits, health data, and genetic information to provide personalized food recommendations to improve health outcomes.
- Clinic-ready Imaging Devices and Protocols for Visualizing the Inner Ear with High Accuracy: Development of non-destructive technologies to image the inner ear’s anatomy and function in human patients.
- Advanced Continuously Wearable Blood Pressure Monitoring Technologies: New technologies for home blood pressure monitoring that can integrate into wearable physiological monitoring systems or function as standalone devices.
If your company has considered applying for ARPA-H funding, your federal funding journey starts here. EverGlade Consulting is a national consulting that helps organizations win and manage federal awards.
For additional information about EverGlade Consulting, reach out to: [email protected]
